Cambridge Open Engage home
What is Cambridge Open Engage?
How to Submit
Browse
About
News [opens in a new tab]

meso-Antracenyl-BODIPY dyad as a new photocatalyst in ATRA reac-tions

30 August 2021, Version 1
Working Paper
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

We demonstrate that because of the efficient generation of triplet excited state under UV or visible-light irradiation, meso-antracenyl-BODIPY donor-acceptor dyad can catalyze ATRA reactions between bromomalonate and alkenes. This finding paves the way for the design and application of the new type of heavy atom-free organic chromophores for photocatalysis.

Keywords

Donor-Acceptor dyad
BODIPY
triplet state
ATRA
Photocatalysis

Supplementary materials

Title
Description
Actions
Title
Supporting Information
Description
Experimental details and spectral characterizations of the catalysts and obtained compounds.
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.

Now Published

meso-Antracenyl-BODIPY Dyad as a New Photocatalyst in Atom-Transfer Radical Addition Reactions [opens in a new tab]
Sara Abuhadba, Miu Tsuji, Tomoyasu Mani, Tatiana V. Esipova journal article
ACS Omega , Volume 6, Issue 48
Online publication date: Nov 19, 2021

Version History

Aug 30, 2021 Version 1

Metrics

757
296
0
Views
Downloads
Citations

License

CC logo
CC
BY logo
BY
NC logo
NC
The content is available under CC BY NC 4.0 [opens in a new tab]

DOI

10.26434/chemrxiv-2021-899lq
D O I: 10.26434/chemrxiv-2021-899lq [opens in a new tab]

Author’s competing interest statement

The author(s) have declared they have no conflict of interest with regard to this content

Ethics

The author(s) have declared ethics committee/IRB approval is not relevant to this content

Share